Hong Kong shares rose 130 points or 0.5% to 25,264 on Tuesday morning deals, extending gains for the fourth straight session while staying at their highest level since November 2021. All sectors advanced, supported by a notable rise in U.S. futures after President Trump announced a trade deal with Japan involving a 15% tariff. Meanwhile, mainland markets also notched to a 3-1/2-year high, driven by the launch of a $170 billion hydropower project in Tibet, easing U.S.-China trade tensions, and fresh policy support from Beijing for key sectors including machinery, autos, and electrical equipment. Investors also positioned ahead of China’s upcoming Politburo meeting later this month, which is expected to shape economic policy for the remainder of the year. Genscript Biotech surged 5.8% after forecasting a return to profit in the first half. Other top gainers included Citic Ltd. (2.5%), Innovent Biologics (2.3%), Techtronic Industries (2.1%), and Tencent Holdings (1.6%).